[Federal Register Volume 88, Number 248 (Thursday, December 28, 2023)]
[Notices]
[Page 89696]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-28615]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--CE24-034, Rigorous Evaluation of Policies for 
Their Impacts on the Primary Prevention of Multiple Forms of Violence; 
Amended Notice of Closed Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--CE24-034, Rigorous Evaluation of Policies for their Impacts on 
the Primary Prevention of Multiple Forms of Violence; February 27, 
2024, 8 a.m.-5 p.m., EST, web conference, in the original Federal 
Register notice. The meeting notice was published in the Federal 
Register on October 24, 2023, Volume 88, Number 204, page 73020.
    The notice is being amended to change the date to a two-day meeting 
and to change the times. The notice should read as follows:
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--CE24-034, Rigorous Evaluation of 
Policies for their Impacts on the Primary Prevention of Multiple Forms 
of Violence.
    Dates: February 27-28, 2024.
    Times: 8:30 a.m.-5:30 p.m., EST.
    The meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Carlisha Gentles, Pharm.D., B.C.P.S., 
C.D.C.E.S., Scientific Review Officer, National Center for Injury 
Prevention and Control, Centers for Disease Control and Prevention, 
4770 Buford Highway NE, Mailstop S106-9, Atlanta, Georgia 30341. 
Telephone: (770) 488-1504; Email: [email protected].
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-28615 Filed 12-27-23; 8:45 am]
BILLING CODE 4163-18-P